Article

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3…

medRxiv · 2019 · Ashraf, N. S.; Sutton, J. R.; Yang, Y.; Ranxhi, B.; Libohova, K.; Shaw, E. D.; Barget, A. J.; Todi, S. V.; Paulson, H. L.; Costa, M. d. C.

Key facts

Title Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia Type 3 disease protein
First author Ashraf, N. S.; Sutton, J. R.; Yang, Y.; Ranxhi, B.; Libohova, K.; Shaw, E. D.; Barget, A. J.; Todi, S. V.; Paulson, H. L.; Costa, M. d. C.
Journal medRxiv
Published Jul 2, 2019
DOI 10.1101/690818
Devices mentioned K013842
Product codes mentioned CEK, JJH, JPK, MVU, PPM

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature